Drug Litigation May 1, 2026 · 8 min read

Ozempic vs. Wegovy vs. Mounjaro: Are There Differences in Your Lawsuit?

Patients and attorneys frequently ask whether Ozempic, Wegovy, and Mounjaro lawsuits are the same or different. The answer is: they involve related but distinct drugs, different manufacturers, and overlapping but not identical legal theories. Understanding the differences helps you know which products apply to your situation and which defendants your attorney will target.

The Key Differences Between These Drugs

Ozempic and Wegovy both contain semaglutide but are approved for different uses: Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is approved for chronic weight management. Both are manufactured by Novo Nordisk. Mounjaro contains tirzepatide — a different molecule that acts on both GLP-1 and GIP receptors — and is approved for type 2 diabetes; its weight-loss version, Zepbound, is approved for obesity. Mounjaro and Zepbound are manufactured by Eli Lilly.

Ozempic (semaglutide) — Novo Nordisk — type 2 diabetes
Wegovy (semaglutide, higher dose) — Novo Nordisk — chronic weight management
Rybelsus (semaglutide, oral) — Novo Nordisk — type 2 diabetes
Mounjaro (tirzepatide) — Eli Lilly — type 2 diabetes
Zepbound (tirzepatide) — Eli Lilly — obesity
Victoza/Saxenda (liraglutide) — Novo Nordisk — diabetes/weight loss

Which Risks Are Common to All GLP-1 Drugs

The most common risks alleged in lawsuits — gastroparesis, pancreatitis, gallbladder disease, and intestinal obstruction — appear to be class-wide risks applicable to all GLP-1 receptor agonists. These risks stem from GLP-1 receptors' presence in the gastrointestinal tract and pancreas, which are activated by all drugs in this class. This means patients who used any of these drugs and developed a qualifying condition may have a claim, not just Ozempic users specifically.

Used a GLP-1 drug and suffered serious side effects?

Find out if you may qualify — free case review.

Check Eligibility arrow_forward

Different Defendants: Novo Nordisk vs. Eli Lilly

Because Ozempic/Wegovy and Mounjaro/Zepbound are made by different companies, the lawsuits target different defendants. Claims based on semaglutide products name Novo Nordisk; claims based on tirzepatide products name Eli Lilly. Some plaintiffs who used both products may have claims against both manufacturers. The litigation is consolidated in a federal MDL in Pennsylvania, which covers claims against both manufacturers.

What If You Used Multiple GLP-1 Drugs

Patients who used multiple GLP-1 medications — for example, starting on Victoza then switching to Ozempic, or using Mounjaro after Ozempic — may have claims against multiple defendants. Your attorney will review your complete medication history to identify every period of GLP-1 drug exposure and determine the likely causation of your specific condition. The drug used closest in time to the onset of your symptoms is typically the primary focus.

Frequently Asked Questions

Can I sue if I used a GLP-1 drug not yet named in the litigation?expand_more

The litigation is ongoing and expanding. If you used a GLP-1 drug not yet prominently featured in the MDL but developed a qualifying condition, an attorney can evaluate whether your claim fits under the existing legal theories. The core argument — that GLP-1 drugs cause serious GI side effects and manufacturers failed to warn — applies across the drug class.

Is there one class action I can join for all GLP-1 drugs?expand_more

The litigation is structured as a multidistrict litigation (MDL), not a traditional class action. Individual cases maintain their own identity, damages, and outcomes. All pending GLP-1 personal injury cases are coordinated in federal court in Pennsylvania for pretrial proceedings.

What if I got sick from a generic GLP-1 drug?expand_more

As of 2026, branded GLP-1 drugs dominate the market. However, if you used a compounded semaglutide product from a compounding pharmacy, those claims may involve different legal theories and defendants. Consult an attorney about the specific product you used.

edit_note

SuperLawsuits Editorial Team

Reviewed by licensed attorneys in our network